Sanctuary Advisors LLC Has $6.67 Million Holdings in Ecolab Inc. $ECL

Sanctuary Advisors LLC lessened its holdings in Ecolab Inc. (NYSE:ECL) by 7.2% during the fourth quarter, HoldingsChannel reports. The fund owned 25,399 shares of the basic materials company’s stock after selling 1,980 shares during the quarter. Sanctuary Advisors LLC’s holdings in Ecolab were worth $6,668,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in ECL. Brighton Jones LLC raised its holdings in shares of Ecolab by 164.7% in the 4th quarter. Brighton Jones LLC now owns 3,700 shares of the basic materials company’s stock worth $867,000 after acquiring an additional 2,302 shares during the last quarter. Sivia Capital Partners LLC raised its holdings in shares of Ecolab by 39.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,384 shares of the basic materials company’s stock worth $373,000 after acquiring an additional 394 shares during the last quarter. Schnieders Capital Management LLC. raised its holdings in shares of Ecolab by 22.9% in the 2nd quarter. Schnieders Capital Management LLC. now owns 1,166 shares of the basic materials company’s stock worth $314,000 after acquiring an additional 217 shares during the last quarter. NewEdge Advisors LLC raised its holdings in shares of Ecolab by 0.8% in the 2nd quarter. NewEdge Advisors LLC now owns 21,096 shares of the basic materials company’s stock worth $5,684,000 after acquiring an additional 171 shares during the last quarter. Finally, CIBC Asset Management Inc raised its holdings in shares of Ecolab by 49.4% in the 2nd quarter. CIBC Asset Management Inc now owns 58,421 shares of the basic materials company’s stock worth $15,741,000 after acquiring an additional 19,324 shares during the last quarter. Institutional investors and hedge funds own 74.91% of the company’s stock.

Trending Headlines about Ecolab

Here are the key news stories impacting Ecolab this week:

• Positive Sentiment: Q1 results showed revenue growth and solid operating momentum — reported revenue of ~$4.07B (above consensus) and adjusted EPS $1.70, with organic sales acceleration led by Life Sciences, Global High?Tech and other end markets. This supports the company’s growth narrative. Read More.
• Positive Sentiment: Life Sciences growth: Ecolab opened a new Bioprocessing Applications Lab in Dongtan, Korea — expanding its bioprocessing capabilities in Asia and strengthening long?term growth prospects in a high?growth end market. Read More.
• Positive Sentiment: Company maintained FY2026 adjusted EPS outlook of $8.43–$8.63, signaling management confidence in hitting full?year targets despite near?term headwinds. Read More.
• Neutral Sentiment: Corporate event: Ecolab will webcast its virtual annual meeting May 7 (useful for governance watchers but unlikely to move the stock materially). Read More.
• Neutral Sentiment: Market commentary and screens picked Ecolab as a name with positive earnings momentum — a signal that some quant/earnings?beat models still favor the stock. Read More.
• Negative Sentiment: Q2 guidance came in mostly below consensus (Q2 EPS guide $2.02–2.12 vs. ~$2.11 consensus) and management flagged cost pressure related to geopolitical developments (reported coverage cited Iran?related cost impacts), which pressured sentiment. Read More. Read More.
• Negative Sentiment: Analyst reaction: Erste Group trimmed FY2026/27 EPS estimates slightly and retains a Hold — small cuts and a cautious tone add selling pressure after the print. (Analyst note referenced in coverage.)

Wall Street Analyst Weigh In

A number of research firms recently weighed in on ECL. Robert W. Baird lowered their target price on shares of Ecolab from $320.00 to $296.00 and set an “outperform” rating on the stock in a report on Tuesday, March 24th. Erste Group Bank lowered shares of Ecolab from a “buy” rating to a “hold” rating in a research note on Friday, January 23rd. BMO Capital Markets increased their price objective on shares of Ecolab from $323.00 to $345.00 and gave the company an “outperform” rating in a research note on Friday, February 13th. Mizuho set a $335.00 price objective on shares of Ecolab in a research note on Wednesday, February 11th. Finally, Evercore reiterated an “outperform” rating and issued a $312.00 price objective on shares of Ecolab in a research note on Wednesday, February 18th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $322.82.

Insider Buying and Selling

In other news, CEO Christophe Beck sold 20,000 shares of the stock in a transaction that occurred on Tuesday, February 24th. The shares were sold at an average price of $307.37, for a total transaction of $6,147,400.00. Following the completion of the transaction, the chief executive officer directly owned 90,794 shares of the company’s stock, valued at $27,907,351.78. This represents a 18.05% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Tracy B. Mckibben sold 1,265 shares of the stock in a transaction that occurred on Wednesday, February 25th. The shares were sold at an average price of $308.66, for a total transaction of $390,454.90. Following the transaction, the director directly owned 11,358 shares of the company’s stock, valued at $3,505,760.28. This represents a 10.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.50% of the stock is owned by corporate insiders.

Ecolab Stock Down 3.9%

Ecolab stock opened at $256.65 on Thursday. Ecolab Inc. has a twelve month low of $243.79 and a twelve month high of $309.27. The firm has a 50 day moving average price of $276.55 and a 200-day moving average price of $273.34. The company has a market capitalization of $72.48 billion, a P/E ratio of 35.25, a P/E/G ratio of 2.12 and a beta of 1.02. The company has a quick ratio of 0.81, a current ratio of 1.08 and a debt-to-equity ratio of 0.75.

Ecolab (NYSE:ECL) last released its earnings results on Tuesday, April 28th. The basic materials company reported $1.70 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.70. Ecolab had a net margin of 12.91% and a return on equity of 22.73%. The firm had revenue of $4.07 billion during the quarter, compared to the consensus estimate of $4.02 billion. During the same period in the prior year, the firm earned $1.50 EPS. The company’s revenue was up 10.0% compared to the same quarter last year. Ecolab has set its FY 2026 guidance at 8.430-8.630 EPS and its Q2 2026 guidance at 2.020-2.120 EPS. As a group, equities analysts predict that Ecolab Inc. will post 8.45 EPS for the current year.

Ecolab Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 15th. Stockholders of record on Tuesday, March 17th were given a dividend of $0.73 per share. This represents a $2.92 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date of this dividend was Tuesday, March 17th. Ecolab’s dividend payout ratio is currently 39.51%.

Ecolab Profile

Ecolab, Inc is a global provider of water, hygiene and infection prevention solutions and services. The company develops and supplies cleaning and sanitizing chemicals, dispensing equipment, water-treatment systems, pest elimination services and related technologies designed to help businesses maintain clean, safe and efficient operations. Its offerings span both products and onsite services, often paired with technical support and training.

Ecolab serves a broad range of end markets including hospitality and foodservice, food and beverage processing, healthcare, manufacturing and industrial operations, and energy and utilities.